化工社化工社 化学情報印刷レポート · 研究参考用
Tetrapropylammonium → 1-(3-Isopropyl-1,2,4-oxadiazol-5-YL)piperidin-4-one
関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|---|---|---|
| 反応物 | Tetrapropylammonium | HCID 9559 | — |
| 反応物 | Methyl morpholine oxide | HCID 82029 | — |
| 反応物 | 1-(3-Isopropyl-1,2,4-oxadiazol-5-YL)piperidin-4-OL | HCID 21897744 | — |
| 溶媒 | Dichloromethane | HCID 6344 | — |
| 生成物 | 1-(3-Isopropyl-1,2,4-oxadiazol-5-YL)piperidin-4-one | HCID 66915348 | — |
反応手順
1-[3-(Propan-2-yl)-1,2,4-oxadiazol-5-yl]piperidin-4-ol (0.5 g) is dissolved in dichloromethane (75 mL) and 4 A molecular sieves (4 g) is added followed by N-methylmorpholine-N-oxide (1.52 g) and tetrapropylammonium perrhutenate (0.018 g) and the mixture is stirred at room temperature for 1 h. The reaction is filtered through celite and the filtrate is washed with water (2×50 mL). The combined aqueous layers are extracted with dichloromethane (100 mL). The organic layers are combined, dried over Na2SO4, filtered and concentrated to a dark liquid which crystallized upon standing to yield the title compound.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 特許番号 | US08822471B2 |
| 出典データセット | uspto-grants-2014_09 |
| ORD ID | ord-14b90347dac24a2196daa5dccd2838e0 |
| 出典メモ | uspto-grants-2014_09 |